Literature DB >> 8220881

Effects of L- and D-arginine and some related esters on the cytosolic mechanisms of alpha-thrombin-induced human platelet activation.

P Failli1, E Cecchi, C Ruocco, A Fazzini, A Giotti.   

Abstract

1. In Fura-2 preloaded human platelets, the increase in cytosolic calcium induced by alpha-thrombin was reduced by some L- and D-arginine ester compounds the IC50 (microM) values of which were 7.4 for TAEE, 56.9 for BAEE, 77.6 for TAME, 560 for T(d)AME, 656.3 for L-ArgOMe and 2206.7 for D-ArgOMe. alpha-tosyl-L-Arginine, L- and D-arginine were inactive. 2. The inhibitory activity of the L-arginine esters was not modified when platelets were pretreated with 100 microM N omega-monomethyl-L-arginine. 3. The L-arginine esters did not increase cyclic GMP content in platelets either in the presence or absence of indomethacin and apyrase at rest and after alpha-thrombin stimulation. 4. The kinetic parameters of platelet Na+/H+ antiporter (amiloride-inhibitable, evaluated after cytosolic nigericin-induced acidification) were modified by L- and D-arginine esters, while the native amino acids were ineffective. 5. The inhibitory effects of the L- and D-arginine esters on platelet activation appear to be mainly due to their inhibitory effect on Na+/H+ antiporter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8220881      PMCID: PMC2175985          DOI: 10.1111/j.1476-5381.1993.tb13794.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  INHIBITION OF ADP-INDUCED PLATELET AGGREGATION BY SUBSTITUTED AMINO-ACIDS.

Authors:  E W SALZMAN; D A CHAMBERS
Journal:  Nature       Date:  1964-11-14       Impact factor: 49.962

2.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Activation of sodium-proton exchange is not a prerequisite for Ca2+ mobilization and aggregation in human platelets.

Authors:  L Hunyady; B Sarkadi; E J Cragoe; A Spät; G Gárdos
Journal:  FEBS Lett       Date:  1987-12-10       Impact factor: 4.124

4.  Activation of sodium-proton exchange is a prerequisite for Ca2+ mobilization in human platelets.

Authors:  W Siffert; J W Akkerman
Journal:  Nature       Date:  1987 Jan 29-Feb 4       Impact factor: 49.962

5.  Inhibition of platelet aggregation by amiloride.

Authors:  W Siffert; S Gengenbach; P Scheid
Journal:  Thromb Res       Date:  1986-10-15       Impact factor: 3.944

6.  Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets.

Authors:  M W Radomski; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1987-09       Impact factor: 8.739

7.  Inhibition of platelet aggregation by protease inhibitors. Possible involvement of proteases in platelet aggregation.

Authors:  N Aoki; K Naito; N Yoshida
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

8.  Elevation of pHi is not an essential step in calcium mobilisation in fura-2-loaded human platelets.

Authors:  A W Simpson; T J Rink
Journal:  FEBS Lett       Date:  1987-09-28       Impact factor: 4.124

9.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.

Authors:  R M Palmer; A G Ferrige; S Moncada
Journal:  Nature       Date:  1987 Jun 11-17       Impact factor: 49.962

10.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite.

Authors:  J B Hibbs; R R Taintor; Z Vavrin
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

View more
  1 in total

1.  Iloprost antagonizes the increase in internal calcium concentration induced by alpha-thrombin in human platelets: a study of desensitization.

Authors:  E Cecchi; L Capone; C Ruocco; A Fazzini; A Mugelli; A Giotti; P Failli
Journal:  Cardiovasc Drugs Ther       Date:  1995-12       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.